Larsucosterol
- Generic Name
- Larsucosterol
- Drug Type
- Small Molecule
- Chemical Formula
- C27H46O5S
- CAS Number
- 884905-07-1
- Unique Ingredient Identifier
- UGX2V7MGMZ
DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2022-08-05
- Lead Sponsor
- Durect
- Target Recruit Count
- 2
- Registration Number
- NCT04447404
- Locations
- ๐บ๐ธ
Site 03, Newark, New Jersey, United States
A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC)
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2022-10-17
- Lead Sponsor
- Durect
- Target Recruit Count
- 5
- Registration Number
- NCT03394781
- Locations
- ๐บ๐ธ
Charlotte Mecklenburg Hospital, Charlotte, North Carolina, United States
๐บ๐ธCalifornia Pacific Medical Center, San Francisco, California, United States
๐บ๐ธSouthern Therapy and Advanced Research, Jackson, Mississippi, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath